207940:KRXSamsung Biologics Co.,Ltd. Analysis
Data as of 2026-06-01 - not real-time
₩1,394,000.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Samsung Biologics is trading at KRW 1,394,000, well below its 20‑day (KRW 1,418,600), 50‑day (KRW 1,504,520) and 200‑day (KRW 1,651,396) simple moving averages, signaling a short‑term bearish bias. The RSI of 42.4 suggests neutral momentum, while the MACD histogram has turned positive (+2,564), hinting at a possible bullish reversal. However, the DCF‑derived fair value of KRW 884,179 is far beneath the current price, and the forward P/E of 28.9 exceeds the industry average of 27.6, indicating that the stock may be overvalued on a valuation basis. Volume is on a decreasing trend, and the 30‑day volatility of 27.4 % adds to the near‑term risk, though the beta of 0.54 tempers market‑wide swings.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above the identified support level of KRW 1,300,000
- Decreasing trading volume and bearish SMA positioning
- Potential short‑term disruption from pending labor‑union actions
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong Q1 revenue and operating profit growth
- U.S. manufacturing acquisition expanding addressable market
- Analyst consensus target price implying >50% upside
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- High operating margins and solid free cash flow generation
- Continued capacity expansion (Plant 5) and diversified global footprint
- Sustained demand for CDMO services in biotech and mRNA sectors
Key Metrics & Analysis
Financial Health
Revenue Growth25.80%
Profit Margin39.01%
P/E Ratio28.9
ROE18.25%
ROA9.43%
Debt/Equity15.08
Op. Cash Flow₩2332.5B
Free Cash Flow₩1116.9B
Industry P/E27.6
Technical Analysis
TrendBearish
RSI42.4
Support₩1,300,000.00
Resistance₩1,498,000.00
MA 20₩1,418,600.00
MA 50₩1,504,520.00
MA 200₩1,651,395.81
MACDBullish
VolumeDecreasing
Fear & Greed Index94.07
Valuation
Fair Value₩884,178.97
Target Price₩2,104,879.80
Upside/Downside51.00%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.54
Volatility27.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.